Molecular Generative Model Based On Adversarially Regularized Autoencoder
Not on the map. Why?
Abstract (arXiv)
Deep generative models are attracting great attention as a new promising approach for molecular design. All models reported so far are based on either variational autoencoder (VAE) or generative adversarial network (GAN). Here we propose a new type model based on an adversarially regularized autoencoder (ARAE). It basically uses latent variables like VAE, but the distribution of the latent variables is obtained by adversarial training like in GAN. The latter is intended to avoid both inappropriate approximation of posterior distribution in VAE and difficulty in handling discrete variables in GAN. Our benchmark study showed that ARAE indeed outperformed conventional models in terms of validity, uniqueness, and novelty per generated molecule. We also demonstrated successful conditional generation of drug-like molecules with ARAE for both cases of single and multiple properties control. As a potential real-world application, we could generate EGFR inhibitors sharing the scaffolds of known active molecules while satisfying drug-like conditions simultaneously.
Key facts. Cited by 8 papers in the map (data through 7 Oct 2026). First posted on arXiv 13 Nov 2019.
Builds on
No reference list yet.
Built on by
Citing papers per year: 2021: 1; 2022: 3; 2023: 2; 2024: 1; 2025: 0; 2026: 1.
8 papers.
- 2023ChemSpaceAL: An Efficient Active Learning Methodology Applied to Protein-Specific Molecular Generationcited by 8
- 2022Probabilistic Transformer: Modelling Ambiguities and Distributions for RNA Folding and Molecule Designcited by 7
- 2023Decoding Structure-Spectrum Relationships with Physically Organized Latent Spacescited by 3
- 2021An In-depth Summary of Recent Artificial Intelligence Applications in Drug Designcited by 1
- 2022Generative models and Bayesian inversion using Laplace approximationcited by 1
- 2022LatentGAN Autoencoder: Learning Disentangled Latent Distributioncited by 0
- 2024CardioGenAI: A Machine Learning-Based Framework for Re-Engineering Drugs for Reduced hERG Liabilitycited by 0
- 2026A Systematic Evaluation of Molecule Generation Models for De Novo Drug Design: From Benchmarks to Practical Insightscited by 0
- 2026A Systematic Evaluation of Molecule Generation Models for De Novo Drug Design: From Benchmarks to Practical Insights9 Sep 2026
- 2024CardioGenAI: A Machine Learning-Based Framework for Re-Engineering Drugs for Reduced hERG Liability12 Mar 2024
- 2023ChemSpaceAL: An Efficient Active Learning Methodology Applied to Protein-Specific Molecular Generation11 Sep 2023
- 2023Decoding Structure-Spectrum Relationships with Physically Organized Latent Spaces11 Jan 2023
- 2022Probabilistic Transformer: Modelling Ambiguities and Distributions for RNA Folding and Molecule Design27 May 2022
- 2022LatentGAN Autoencoder: Learning Disentangled Latent Distribution5 Apr 2022
- 2022Generative models and Bayesian inversion using Laplace approximation15 Mar 2022
- 2021An In-depth Summary of Recent Artificial Intelligence Applications in Drug Design10 Oct 2021